Texans see need for telemedicine amid the pandemic, Liftoff Houston has launched applications, ChipMonk Bakery is growing, and more of the latest Houston innovation news. Getty Images

From health-conscious cookies reaching fundraising goals to a Houston-wide business competition, the Bayou City's innovation news is pretty diverse.

In InnovationMap's latest roundup of startup and tech short stories, there's everything from telemedicine, fundraising, and more.

Houston baking startup raises money after finding its new home

ChipMonk Baking Company, a consumer packaged goods startup focused on healthy dessert options, has met its goal of $150,000. Photo courtesy of ChipMonk

Houston-based ChipMonk Baking Company, which recently found a new home in a new dedicated production facility, has reached its goal on its investment round on NextSeed.

ChipMonk, which was founded last year to create sweets that use sweeteners monk fruit and allulose for health-conscious consumers, will soon operate in a 2,300-square-foot space at 3042 Antoine Dr. The space is strictly for baking, storage, etc. and will not have a storefront.

Co-founders Jose Hernandez and David Downing have seen a spike in demand since the start of the pandemic, which increased the need to upgrade from shared kitchen space.

"The stay-at-home environment has encouraged many people to think more about their health and to start cooking and baking more at home. We've been able to offer a delicious option that fits perfectly in this growing trend," says Downing, who also serves as CEO.

ChipMonk's lease begins next month, and, to fund its growth plans, the company launched a its campaign on NextSeed. In just a couple weeks, the startup met its fundraising goal of $150,000.

Cancer nonprofit moves into new space

The Rose has a new facility to better serve patients. Photos courtesy of The Rose

The Rose, a Houston-based breast cancer nonprofit that provides medical services to 40,000 patients annually, has moved into its new space at 6575 West Loop South, suite 275, in May.

"We know this location will allow us to better serve our community," says Dorothy Gibbons, co-founder and CEO of The Rose, in a news release. "During this time of the pandemic, we've added so many safety precautions and will continue to space appointments to allow social distancing. Most of all we want our patients to feel safe and welcome from the moment they walk through our door."

Amid the COVID-19 pandemic, data reports have shown a drop in routine health care, like cervical and breast cancer screenings. Gibbons says the drop in these appointments is concerning and those who postpone routine screening or diagnostic testing could be at risk for developing later stage breast cancer.

"Our message to our patients is breast cancer is not going to wait until this pandemic is over; neither should you. With the projected increase in uninsured women, due to so many job losses, The Rose has to be ready to serve. Now more than ever, we depend on our insured patients to help cover the care for uninsured patients," she says.

Houston business competition opens applications

Small businesses in Houston have until August 10 to apply for the annual Liftoff Houston competition. Photo via liftoffhouston.smapply.org

The city of houston's annual business plan competition, Liftoff Houston, has opened applications. The program, which is sponsored by Capital One Bank, is looking for companies and will award winners in three categories: Product, service, and innovation

Each business that wins will receive a $10,000 cash prize. The competition is focused on early stage startups with revenue less than $10,000 and must have only been in business for less than a year. The companies also must be based in Houston.

Applicants can submit their information online to be considered for the contest. The deadline to apply is August 10.

TMCx company closes $1.53 million seed round

Manatee

Manatee has raised funds for its digital therapy platform. Photo via getmanatee.com

Manatee, a health tech startup based in Denver that was a member of this year's TMCx cohort, has announced it closed its seed funding round at $1.53 million. The company, which provides digital solutions to therapy for children, closed the round at the end of June.

Michigan-based Grand Ventures led the raise and invested alongside The American Family Insurance Institute (AmFam), Telosity, SpringTime Ventures, and notable health care entrepreneurs, Danish Munir, Luke Leninger, and Johnathan Weiner, according to information emailed by Manatee representative.

"Manatee was the first solution we found that really understood kids and their unique needs," says Christopher Neuharth, executive director of digital health and experience at Children's Wisconsin. "They got the dynamics between the child, parent, and therapist – and how to influence behavior change."

Accenture study finds COVID-19 has been a gamechanger for telemedicine

Houston medical organizations pivot to telemedicine and remote care amid COVID-19 crisis

An Accenture study found that most Texans are seeking telehealth amid the pandemic. Getty Images

According to a recent study from Accenture, 89 percent of Texas consumers want telehealth options — and the COVID-19 pandemic deserves the credit for the increased interest.

According to a press release from the company, the research found that:

  • One-fourth of Texans surveyed said they first learned about virtual health care following the outbreak of COVID-19.
  • The number of Texans who said they know a little or a lot about virtual health care increased 25 percent following the outbreak.
  • Approximately nine in 10 Texans surveyed after the pandemic began believe that virtual care options should be available to everyone.

The widespread stay-at-home orders exposed Texans to virtual health care and left a positive impression on receiving care remotely. For instance:

  • An estimated 4.5 million state residents began using virtual health care services since the onset of the pandemic.
  • Nearly half (45 percent) of Texans said they trust a virtual health visit as much as or more than an in-person visit—a 15 percent uptick from the pre-pandemic period.
  • Six out of seven remote-care patients (86 percent) who have continued to use virtual care options during the pandemic said their experience after the start of the COVID-19 outbreak was better or the same as before, and three-quarters (76 percent) said their wait time was shorter or the same.

"A lot of Texans got a taste for what it's like to see their physicians and specialists from the safety and comfort of their home," says Mark Olney, a managing director in Accenture's health practice and the study's lead author. "Now patients are eager to get more of that access, convenience and time savings."

ChipMonk Bakery has seen a growth in their healthy cookie business since the beginning of the pandemic. Photo courtesy of ChipMonk Baking

Houston bakery startup dishes out healthy, low-calorie treats

SWEET ON THESE SWEETS

A Houston bakery is helping Houstonians satisfy their sweet tooth and while also counting their calories. ChipMonk Baking, a local, mail-order bakery, has seen significant growth since the start of the coronavirus pandemic as people look for healthier snacks than what they might find in a typical grocery store.

Founded by David Downing and Jose Hernandez, ChipMonk makes cookies, brownie bites, and other snacks using monk fruit and allulose, a low-calorie (0.4 calories per gram) rare sugar that's found naturally in foods such as raisins, dried figs, and kiwi. Hernandez began developing ChipMonk's recipes to satisfy his taste for cookies after being diagnosed with type-2 diabetes.

"We've refined these recipes and now offer numerous different cookies, dry mixes, and brownie bites which all taste delicious and won't spike your blood sugar," Hernandez says in a statement. "While they're great for people with diabetes, Celiac disease, or those who follow a keto diet, anyone who tries them will enjoy the taste and texture."

Jose Hernandez and David Downing founded ChipMonk Bakery. Photo courtesy of ChipMonk Baking

ChipMonk offers all the usual flavors — white chocolate-macadamia, chocolate chip, lemon, snickerdoodle, etc. — as well as dry mixes for those who want to bake at home. Recently, the company introduced red velvet brownie bites that use gluten-free sunflower seed flower. All of these products, as well as sample boxes, are available via ChipMonk's website; the company does not have a brick-and-mortar storefront.

Based on samples sent to CultureMap, the cookies have a chewy, slightly under-baked texture and a mild sweetness that's similar in flavor and appearance to cookies without their low-carb credentials.

Business has grown steadily over the its first year, according to the company, which has it looking to move from a shared commercial kitchen into its own space. Slated to open this summer, the dedicated bakery would allow Downing and Hernandez to expand both their offerings and the number of people they employ.

"We've received extremely positive feedback from our customers who appreciate having delicious, low-carb treats to enjoy while at home during this difficult time," Downing says. "We're seeing more and more people order for themselves as well as sending our products to friends, relatives, and co-workers."

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”

10+ Houston innovation leaders in the spotlight at SXSW 2026

where to be

Houston's innovation scene will be well represented at South by Southwest (SXSW) this month.

The week-long, Austin-based conference and festival will spotlight some of the Bayou City's leaders in health care, energy, space and more. The event kicks off today, March 12, and runs through March 18. The SXSW Innovation Conference will feature keynotes, workshops, mentoring sessions and more throughout various venues in the city.

Here's who to see and when and where to find them:

March 12

Aileen Allen, venture partner at Mercury Fund

Mentor Session from 4-5:15 p.m. at Hilton Austin Downtown

Allen will host a mentoring session focused on funding, marketing, advertising, PR and the future of work.

March 13

Heath Butler, partner at Mercury Fund

SXSW Pitch-Smart Cities, Transportation, Manufacturing & Logistics from 2:30-3:30 p.m. at the J.W. Marriott

Butler will judge five innovative startups as they pitch their solutions to advance smart cities, enhance transportation systems, modernize manufacturing, transform logistics, and strengthen government infrastructure and civic operations.

Jonathan Cirtain, CEO and president of Axiom Space

The Clock is Ticking for Space - Replacing the ISS from 4-5 p.m. at the J.W. Marriott

Cirtain will discuss Axiom's pursuit of building the world’s first commercial space station.

March 14

Jesse Martinez, founder and CEO of LSA Global

SXSW Pitch-Intelligent Systems, Robotics, & Multisensory Technology from 10-11 a.m. at the J.W. Marriott

Martinez will judge five innovative startups as they pitch their technologies that aim to enhance the way people connect, communicate and share unique life experiences with those around them in a digital ecosystem.

Jennifer Schmitt, head of operations at Rhythm Energy

Powering Texas with Reliable Integrated High-Demand Energy from 10-11 a.m. at Marlow

Schmitt will join a panel to discuss how EirGrid, the state-owned electric power transmission operator in Ireland, is pioneering solutions as the country works toward 80 percent renewable integration by 2030.

Saki Sasagawa, director of business development for JETRO Houston

Now is Japan's Time: Leading the Future with Deep Tech from 10-11 a.m. at the J.W. Marriott

Sasagawa joins a panel that will share real-time insights from diverse perspectives on the forefront of Japan’s deep tech and IP businesses.

March 15

Bosco Lai, CEO and co-founder of Little Place Labs

SXSW Pitch Alumni: Where Are They Now? from 10-11 a.m. at the J.W. Marriott

Lai joins a panel of four former SXSW Pitch winners to share how they leveraged the platform to take their startups to the next level.

Tara Karimi, cofounder and chief science and sustainability officer at Cemvita

South by South America: The Rise of Southern Brazil Tech from 2:30-3:30. p.m. at The Line

Karimi will participate in a panel to discuss how Rio Grande do Sul, Brazil's southernmost state, is attracting elite talent and AI infrastructure and share insights on navigating the next wave of South American tech growth.

March 16

Dr. Pavitra P. Krishnamani, emergency medicine physician at The University of Texas MD Anderson Cancer Center

Viva La Revolution: How the Digital Age is Transforming Wellness from 11:30 a.m.-12:30 p.m. at Hilton Austin Downtown

Krishnamani will discuss the latest advancements and policies that can accelerate the digital age of health care, such as wearables, telehealth and artificial intelligence.

March 18

Charlie Childs, co-founder and CEO of Intero Biosystems

Spinning Out: What It Takes to Build a University Startup from 2:30-3:30 p.m. at The Line

Childs will join founders who spun their companies out of the University of Michigan to share the real story of navigating IP, early capital, team building, market validation and the “valley of death.”

Dr. James Allison, regental chair of immunology and director of The Allison Institute at The University of Texas MD Anderson Cancer Center

Dr. Padmanee Sharma, professor in the Department of Genitourinary Medical Oncology, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center

Beyond Checkpoints: Immunotherapy’s Next Act from 2:30-3:30 p.m. at the J.W. Marriott

Allison and Sharma will sit down with 21-year-old, Stage 4 cancer survivor Sharon Belvin and Time Magazine journalist Alice Park will discuss the future of immunotherapy and what challenges remain.

Last year, Houston startups Little Places Labs and Helix Earth won top prizes in their respective categories at the prestigious SXSW Pitch event, held this year from March 13-14. No Houston startups were named finalists to compete in this year's event.

NASA revamps Artemis moon landing program by modeling it after Apollo

To the moon

NASA is revamping its Artemis moon exploration program to make it more like the fast-paced Apollo program half a century ago, adding an extra practice flight before attempting a high-risk lunar landing with a crew in two years.

The overhaul in the flight lineup came just days after NASA’s new moon rocket returned to its hangar for more repairs, and a safety panel warned the space agency to scale back its overly ambitious goals for humanity’s first lunar landing since 1972.

Artemis II, a lunar fly-around by four astronauts, is off until at least April because of rocket problems.

The follow-up mission, Artemis III, had been targeting a landing near the moon’s south pole by another pair of astronauts in about three years. But with long gaps between flights and concern growing over the readiness of a lunar lander and moonwalking suits, NASA’s new administrator Jared Isaacman announced that mission would instead focus on launching a lunar lander into orbit around Earth in 2027 for docking practice by astronauts flying in an Orion capsule.

The new plan calls for a moon landing — potentially even two moon landings — by astronauts in 2028.

“Everybody agrees. This is the only way forward,” Isaacman said.

The hydrogen fuel leaks and helium flow problems that struck the Space Launch System rocket on the pad at NASA's Kennedy Space Center in February also plagued the first Artemis test flight without a crew in 2022.

Another three-year gap was looming between Artemis II and the moon landing by astronauts as originally envisioned, Isaacman said.

Isaacman stressed that “it should be incredibly obvious” that three years between flights is unacceptable. He'd like to get it down to one year or even less.

Isaacman, a tech billionaire who bought his own trips to orbit and performed the world’s first private spacewalk, took the helm at NASA in December.

During NASA’s storied Apollo program, he said, astronauts’ first flight to the moon was followed by two more missions before Neil Armstrong and Buzz Aldrin landed on the moon. What's more, he added, the Apollo moonshots followed one another in quick succession, just as the earlier Projects Mercury and Gemini had rapid flight rates, sometimes coming just a few months apart.

Twenty-four Apollo astronauts flew to the moon from 1968 through 1972, with 12 of them landing.

“No one at NASA forgot their history books. They knew how to do this," Isaacman said. “Now we're putting it in action.”

To pick up the pace and reduce risk, NASA will standardize its Space Launch System rockets moving forward, Isaacman said. These are the massive rockets that will launch astronauts to the moon aboard Orion capsules. At the same time, Elon Musk's SpaceX and Jeff Bezos' Blue Origin are speeding up their work on the landers needed to get the astronauts from lunar orbit down to the surface.

Isaacman said next year will see an Orion crew rendezvousing in orbit around Earth with SpaceX's Starship, Blue Origin's Blue Moon or both landers. It's similar to the methodical approach that worked so well during Apollo in the late 1960s, he noted. Apollo 8, astronauts' first flight to the moon, was followed by two more missions before Armstrong and Aldrin aimed for the lunar surface.

“We should be getting back to basics and doing what we know works,” he said.

The Aerospace Safety Advisory Panel recommended that NASA revise its objectives for Artemis III “given the demanding mission goals.” It’s urgent the space agency do that, the panel said, if the United States hopes to safely return astronauts to the moon. Isaacman said the revised Artemis flight plan addresses the panel's concerns and is supported by industry and the Trump administration.